Send us Feedback

GlaxoSmithKline (GSK)
Analysis
Data
Financials
 
 
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 9.08B 8.08B 8.92B 8.80B 10.3B
Short Term Investments 707M 562M 522M 478M 438M
Accounts Receivable 9.76B 9.12B 8.62B 8.92B 9.76B
Inventories 6.20B 5.83B 5.89B 6.44B 6.71B
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 630M 1.23B 373M 469M 488M
Total Current Assets 26.4B 24.8B 24.3B 25.1B 27.7B
Property, Plant & Equipment 14.8B 13.9B 13.5B 14.6B 15.0B
Goodwill & Intangibles 11.8B 11.5B 11.9B 12.8B 16.9B
Other Long-term Assets 2.44B 2.47B 2.41B 2.41B 2.84B
Total Long-Term Assets 33.4B 31.8B 31.8B 34.1B 38.6B
Total Assets 59.7B 56.6B 56.1B 59.2B 66.3B
Accounts Payable 9.07B 8.73B 8.24B 8.50B 9.73B
Accrued Expenses 0 0 0 0 0
Short Term Debt 2.45B 1.37B 1.83B 1.95B 3.02B
Other Current Liabilities 4.00B 4.29B 3.90B 4.43B 5.04B
Total Current Liabilities 15.5B 14.4B 14.0B 14.9B 17.8B
Long Term Debt 22.6B 21.9B 21.7B 21.5B 24.0B
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 1.15B 1.03B 1.03B 818M 1.11B
Other Long-term Liabilities 6.73B 7.35B 7.40B 8.78B 7.94B
Total Long-term Liabilities 30.5B 30.3B 30.1B 31.1B 33.1B
Minority Interest 549M 556M 533M 517M 566M
Total Liabilities 46.5B 45.2B 44.6B 46.0B 50.9B
Preferred Stock 0 0 0 0 0
Common Par 2.51B 2.03B 2.03B 2.33B 2.26B
Additional Paid-In Capital 2.33B 1.91B 1.92B 2.21B 2.15B
Retained Earnings 7.23B 6.65B 6.62B 7.01B 9.12B
Treasury Stock 0 0 0 0 0
Other Equity 1.13B 817M 985M 1.16B 1.31B
Total Shareholder's Equity 13.2B 11.4B 11.6B 12.7B 14.8B
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki